Tech Company Financing Transactions
RiboNova Funding Round
On 3/31/2016, RiboNova raised $250 thousand in funding from BioAdvance Ventures.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 East Lancaster Ave.
Wynnewood, PA 19096
USA
Wynnewood, PA 19096
USA
Phone
Website
Email Address
Overview
RiboNova is a biomedical research company in the Lankenau Institute for Medical Research near Philadelphia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nigel Webb
Chief Medical Officer
Eric Yuen
Chief Scientific Officer
Anthony Hutchinson
Browse more venture capital transactions:
Prev: 3/31/2016: Infinite Uptime venture capital transaction
Next: 3/31/2016: Unleash Immuno Oncolytics venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs